Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 56,861 shares at $55.41 ($3.2M) on 2008-03-24, disclosed to the SEC on 2008-03-26.
Scheduled sale ($3.2M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.41 | 10,321 | $572K | 18.1% |
| 2 | $55.66 | 46,540 | $2.6M | 81.9% |
| Total | $55.61 avg | 56,861 | $3.2M | 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-12-16 | $4.2M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |